Stress-induced increase in skeletal muscle force requires protein kinase A phosphorylation of the ryanodine receptor

被引:51
作者
Andersson, Daniel C. [1 ,2 ]
Betzenhauser, Matthew J. [1 ,2 ]
Reiken, Steven [1 ,2 ]
Umanskaya, Alisa [1 ,2 ]
Shiomi, Takayuki [3 ]
Marks, Andrew R. [1 ,2 ,3 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2012年 / 590卷 / 24期
基金
瑞典研究理事会;
关键词
BETA-ADRENOCEPTOR ACTIVATION; CALCIUM-RELEASE CHANNEL; INTRACELLULAR CALCIUM; HEART-FAILURE; FIBERS; TWITCH; RAT; CA2+;
D O I
10.1113/jphysiol.2012.237925
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Enhancement of contractile force (inotropy) occurs in skeletal muscle following neuroendocrine release of catecholamines and activation of muscle beta-adrenergic receptors. Despite extensive study, the molecular mechanism underlying the inotropic response in skeletal muscle is not well understood. Here we show that phosphorylation of a single serine residue (S2844) in the sarcoplasmic reticulum (SR) Ca2+ release channel/ryanodine receptor type 1 (RyR1) by protein kinase A (PKA) is critical for skeletal muscle inotropy. Treating fast twitch skeletal muscle from wild-type mice with the beta-receptor agonist isoproterenol (isoprenaline) increased RyR1 PKA phosphorylation, twitch Ca2+ and force generation. In contrast, the enhanced muscle Ca2+, force and in vivo muscle strength responses following isoproterenol stimulation were abrogated in RyR1-S2844A mice in which the serine in the PKA site in RyR1 was replaced with alanine. These data suggest that the molecular mechanism underlying skeletal muscle inotropy requires enhanced SR Ca2+ release due to PKA phosphorylation of S2844 in RyR1.
引用
收藏
页码:6381 / 6387
页数:7
相关论文
共 19 条
[1]   Skeletal muscle fatigue: Cellular mechanisms [J].
Allen, D. G. ;
Lamb, G. D. ;
Westerblad, H. .
PHYSIOLOGICAL REVIEWS, 2008, 88 (01) :287-332
[2]   Ryanodine Receptor Oxidation Causes Intracellular Calcium Leak and Muscle Weakness in Aging [J].
Andersson, Daniel C. ;
Betzenhauser, Matthew J. ;
Reiken, Steven ;
Meli, Albano C. ;
Umanskaya, Alisa ;
Xie, Wenjun ;
Shiomi, Takayuki ;
Zalk, Ran ;
Lacampagne, Alain ;
Marks, Andrew R. .
CELL METABOLISM, 2011, 14 (02) :196-207
[3]   Increased mitochondrial Ca2+ and decreased sarcoplasmic reticulum Ca2+ in mitochondrial myopathy [J].
Aydin, Jan ;
Andersson, Daniel C. ;
Hanninen, Sandra L. ;
Wredenberg, Anna ;
Tavi, Pasi ;
Park, Chan Bae ;
Larsson, Nils-Goran ;
Bruton, Joseph D. ;
Westerblad, Hakan .
HUMAN MOLECULAR GENETICS, 2009, 18 (02) :278-288
[4]   Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle [J].
Bellinger, Andrew M. ;
Reiken, Steven ;
Carlson, Christian ;
Mongillo, Marco ;
Liu, Xiaoping ;
Rothman, Lisa ;
Matecki, Stefan ;
Lacampagne, Alain ;
Marks, Andrew R. .
NATURE MEDICINE, 2009, 15 (03) :325-330
[5]  
Bers D., 2001, Excitation-Contraction Coupling and Cardiac Contractile Force, VVolume 237
[6]   THE ACTION OF ADRENALINE ON MAMMALIAN SKELETAL MUSCLE [J].
BROWN, GL ;
BULBRING, E ;
BURNS, BD .
JOURNAL OF PHYSIOLOGY-LONDON, 1948, 107 (01) :115-128
[7]   BETA-ADRENERGIC POTENTIATION OF E-C COUPLING INCREASES FORCE IN RAT SKELETAL-MUSCLE [J].
CAIRNS, SP ;
DULHUNTY, AF .
MUSCLE & NERVE, 1993, 16 (12) :1317-1325
[8]   CHANGES OF TENSION AND [CA2+](I) DURING BETA-ADRENOCEPTOR ACTIVATION OF SINGLE, INTACT FIBERS FROM MOUSE SKELETAL-MUSCLE [J].
CAIRNS, SP ;
WESTERBLAD, H ;
ALLEN, DG .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1993, 425 (1-2) :150-155
[9]   THE EFFECTS OF BETA-ADRENOCEPTOR ACTIVATION ON CONTRACTION IN ISOLATED FAST-TWITCH AND SLOW-TWITCH SKELETAL-MUSCLE FIBERS OF THE RAT [J].
CAIRNS, SP ;
DULHUNTY, AF .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (03) :1133-1141
[10]   Effects of terbutaline on force and intracellular calcium in slow-twitch skeletal muscle fibres of the rat [J].
Ha, TNV ;
Posterino, GS ;
Fryer, MW .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (08) :1717-1724